(Q33342063)

25 July 2017

title

A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation (English)

1 reference

25 July 2017

0 references

liver transplantation

1 reference

1 reference

1 reference

3

Norah Terrault

1 reference

25 July 2017

Jeffrey S Crippin

1

1 reference

25 July 2017

Tim McCashland

series ordinal

2

1 reference

25 July 2017

Patricia Sheiner

series ordinal

4

1 reference

25 July 2017

Michael R Charlton

series ordinal

5

1 reference

25 July 2017

publication date

1 April 2002

1 reference

25 July 2017

published in

Liver Transplantation

1 reference

25 July 2017

volume

8

1 reference

25 July 2017

issue

4

1 reference

25 July 2017

page(s)

350-355

1 reference

Long-term outcome of hepatitis C infection after liver transplantation

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.31748

Causes of graft loss following liver transplantation for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.31748

Predictors of patient and graft survival following liver transplantation for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.31748

High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.31748

Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.31748

Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.31748

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.31748

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.31748

The influence of hepatitis C virus genotypes on the outcome of liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.31748

Reinfection of liver graft by hepatitis C virus after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.31748

Graft loss following liver transplantation in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.31748

Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.31748

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.31748

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.31748

A proposed system for the nomenclature of hepatitis C viral genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.31748

Interferon-alpha therapy for hepatitis C virus infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.31748

Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.31748

Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.31748

An infectious molecular clone of a Japanese genotype 1b hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.31748

21 January 2018

Identifiers

DOI

10.1053/JLTS.2002.31748

1 reference

25 July 2017

1 reference